All In Biotech

NDA 021594 · Intl Medication Sys

Amiodarone Hydrochloride

Amiodarone Hydrochloride · Injection

Discontinued

Last checked: Nov 20, 2026Latest source record: Feb 4, 2004 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2004

Feb 4, 2004

Approved uses

1

Original approval plus efficacy supplements

Registered trials

185

52 Phase 3, 17 recruiting

FAERS reports

9,185

7,993 serious, 1,582 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

1 products under this application
  • AMIODARONE HYDROCHLORIDE · AMIODARONE HYDROCHLORIDE 50MG/ML · INJECTABLE, INJECTION · Discontinued

Clinical trials

Interventional ClinicalTrials.gov studies with "Amiodarone" as an intervention, any sponsor and status, largest first.

All 185 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • dyspnoea997
  • off label use869
  • asthenia835
  • fatigue770
  • drug ineffective688
  • product use in unapproved indication648
  • nausea545
  • cough528
  • dizziness471
  • atrial fibrillation465
  • pneumonia449
  • vomiting439

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200459
2005106
200683
200768
200841
2009108
2010119
2011140
2012332
2013144
2014142
2015157
2016179
2017492
2018479
2019596
2020592
2021833
2022916
2023916
20241,042
20251,033
2026606

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 1,018 on PubMed

Sponsor: Intl Medication Sys

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.